A Non-Invasive CFD-Optimized Waveform Stimulation Strategy Predicted to Enhance Glymphatic Clearance of Alzheimer's-Related Proteins by 30–70%

Alzheimer's disease affects more than 55 million people worldwide and remains one of the greatest healthcare challenges of our time. Growing evidence suggests that impaired glymphatic clearance—the brain's natural waste-removal system—contributes to the accumulation of neurotoxic proteins such as Amyloid-β and Tau. Aging progressively reduces arterial pulsatility and vasomotion, diminishing cerebrospinal fluid (CSF) transport through perivascular spaces and limiting metabolic waste clearance. Current therapeutic approaches are largely pharmaceutical or require wearable devices that often suffer from poor long-term compliance.

GlymphMirror introduces a new paradigm in preventive neurotechnology by transforming an ordinary household mirror into a personalized therapeutic platform. Rather than relying on wearable sensors or fixed stimulation protocols, the system continuously senses the user's physiology, constructs an individualized vascular model, computationally optimizes treatment parameters, and delivers adaptive photobiomodulation through a fully contactless closed-loop control system.

The platform begins with remote photoplethysmography (rPPG) acquired using a high-resolution CMOS camera embedded behind the mirror. By analyzing subtle facial skin color variations, GlymphMirror estimates heart rate, pulse waveform morphology, vascular pulsatility, beat-to-beat timing, and arterial stiffness indicators without requiring physical contact. These physiological measurements are processed locally using edge artificial intelligence, preserving privacy while enabling real-time analysis.

Unlike conventional photobiomodulation systems that deliver identical stimulation to every user, GlymphMirror continuously builds a personalized physiological digital twin representing the individual's vascular dynamics. This digital model evolves over repeated sessions as cardiovascular characteristics change, allowing therapy to become increasingly individualized.

The engineering foundation combines computational fluid dynamics, porous-media transport modeling, and physiological signal processing. Brain tissue is represented using Brinkman-extended Darcy equations coupled with transient pulsatile flow and transport equations describing cerebrospinal fluid movement within perivascular spaces. Patient-specific vascular pulsatility derived from rPPG measurements serves as the computational boundary condition. Waveform timing, modulation frequency, duty cycle, synchronization phase, and illumination duration are optimized to maximize convective glymphatic transport while maintaining safe optical exposure.

Near-infrared photobiomodulation (810–850 nm) is then synchronized with the optimized physiological waveform. The central engineering hypothesis is that heartbeat-synchronized illumination enhances nitric oxide-mediated vasomotor responses more effectively than conventional fixed-frequency stimulation, thereby improving physiological CSF-interstitial fluid exchange. Multiphysics simulations predict that optimized stimulation protocols could increase convective interstitial transport efficiency by approximately 30–70%, depending on vascular stiffness. These values represent computational predictions requiring future experimental and clinical validation.

Safety is integrated into the architecture from the outset. Because near-infrared light is invisible and does not trigger the natural pupillary reflex, the vision system continuously tracks eye position and dynamically disables LED regions directed toward the pupils while maintaining therapeutic illumination over the forehead and temporal regions.

If experimentally validated, GlymphMirror could establish a new class of home-based preventive neurotechnology by integrating contactless physiological sensing, personalized digital twins, computational fluid dynamics, adaptive photobiomodulation, and intelligent closed-loop therapy into a single consumer-friendly platform. Rather than replacing pharmaceutical treatment, GlymphMirror aims to augment the brain's natural waste-clearance mechanisms, making personalized brain healthcare as routine as looking into a mirror each morning.